What Researchers Did
This retrospective study investigated the efficacy of combining hyperbaric oxygen therapy (HBOT) with systemic steroid therapy for sudden sensorineural hearing loss (SSNHL).
What They Found
Among 505 SSNHL patients, 102 received systemic steroids (SS) plus hyperbaric oxygen therapy (HBOT), while 403 received SS alone. The SS + HBOT group showed significantly better improvement in the pure-tone audiometry threshold (PTA) at low frequencies (24.0 ± 14.6 dB vs. 17.6 ± 14.2 dB, p 50 dB.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss might benefit from combined hyperbaric oxygen therapy and steroid treatment, particularly if started within 11 days of diagnosis. This approach could lead to better hearing recovery, especially for younger individuals and those with more severe initial hearing loss.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.
Study Limitations
As a retrospective study, it may be subject to selection bias and unmeasured confounding factors.